- Amendment of VAT Regulations 2017 to grant exemptions on active pharmaceutical inputs and finished products
- Addition of inputs and products to exemption list could reduce importation costs
- Removal of VAT on these items could lead to cost savings for businesses
Source: assets.kpmg.com
Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.
